Enhancing structural diversity of terpenoids by multisubstrate terpene synthases

• Min Li and
• Hui Tao

Beilstein J. Org. Chem. 2024, 20, 959–972, doi:10.3762/bjoc.20.86

• products, 3-ethyl-3-buten-1-ol (139) and 3-propyl-3-buten-1-ol (140), have potent fuel properties, highlighting the potential of this strategy for producing isoprenol analogs as next-generation biofuels (Figure 10b) [62]. Conclusion During terpenoid biosynthesis, most TSs have strict substrate selectivity

• terpenoids via genome mining. Nevertheless, for drug development, the accumulated terpene skeletons still require further functionalization, which requires additional genome-mining efforts for the discovery of tailored enzymes. Researchers have successfully expanded the chemical space of terpenoid

• biosynthesis using noncanonical prenyl substrates, which were synthesized using chemical approaches or via biosynthetic pathways. Many new terpenoids have been derived from chemically prepared prenyl analogs for decades, and until recently, the conversion of enzymatically modified noncanonical substrates has

Discovery and biosynthesis of bacterial drimane-type sesquiterpenoids from Streptomyces clavuligerus

• Dongxu Zhang,
• Wenyu Du,
• Xingming Pan,
• Xiaoxu Lin,
• Fang-Ru Li,
• Qingling Wang,
• Qian Yang,
• Hui-Min Xu and
• Liao-Bin Dong

Beilstein J. Org. Chem. 2024, 20, 815–822, doi:10.3762/bjoc.20.73

• analogs. This discovery not only broadens the known chemical diversity of DMTs from bacteria, but also provides new insights into DMT biosynthesis in bacteria. Keywords: bacterial terpenoid; cytochrome P450s; drimane-type sesquiterpenoid; Streptomyces clavuligerus; terpenoid biosynthesis; Introduction

Bacterial terpene biosynthesis: challenges and opportunities for pathway engineering

• Eric J. N. Helfrich,
• Geng-Min Lin,
• Christopher A. Voigt and
• Jon Clardy

Beilstein J. Org. Chem. 2019, 15, 2889–2906, doi:10.3762/bjoc.15.283

• genome does not guarantee their partnership [87]. Studies of CYPs in bacterial terpenoid biosynthesis lags behind those of cyclases, and only a handful of examples are found in literature (Supporting Information File 1, Table S2). CYPs mostly catalyze prototypical hydroxylations, sometimes followed by

• step and then modified by tailoring reactions make terpenoid biosynthesis particularly amenable for generating non-natural variants through engineering. It is easy to imagine that the combinatorial pairing of promiscuous TCs and CYPs harbors great potential to achieve this goal, and the integration of

• assist in refining our understanding of bacterial terpenoid biosynthesis. Examples of bioactive terpenoids. Repetitive electrophilic and nucleophilic functionalities in terpene and type II PKS-derived polyketide biosynthesis. a) Schematic representation. b) Type II PKS-derived polyketide biosynthesis. c

Opportunities and challenges for the sustainable production of structurally complex diterpenoids in recombinant microbial systems

• Katarina Kemper,
• Max Hirte,
• Markus Reinbold,
• Monika Fuchs and
• Thomas Brück

Beilstein J. Org. Chem. 2017, 13, 845–854, doi:10.3762/bjoc.13.85

• for highest yield of plasmid systems generally precedes genomic integration; 5: Isoprenoid precursor supply: precursor flux has to be balanced carefully to avoid metabolic overload and accumulation of unwanted byproducts; 6: Downstream terpenoid biosynthesis using heterologous enzymes; 7: Upscaling of

Lipids: fatty acids and derivatives, polyketides and isoprenoids

• Jeroen S. Dickschat

Beilstein J. Org. Chem. 2017, 13, 793–794, doi:10.3762/bjoc.13.78

• biosynthetically related polyketide pathways, and terpenoid biosynthesis. I hope that the present Thematic Series of the Beilstein Journal of Organic Chemistry on the interdisciplinary topic of “Lipids” will cover many topics of high interest to readers from chemistry, biochemistry, biophysics, medicine, pharmacy